Population pharmacokinetics of high-dose thiopental in patients with cerebral injuries

Clinical Pharmacology and Therapeutics

Volumn 62, Issue 1, 1997, Pages 15-20

  Russo, Hélène ^b   Simon, Nicolas ^b   Duboin, Marie Paule ^b   Urien, Saïk ^a  

^a FACULTÉ DE MÉDECINE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

THIOPENTAL;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN INJURY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PHARMACOKINETICS; POPULATION RESEARCH; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; BRAIN INJURIES; FEMALE; HUMANS; MALE; MIDDLE AGED; THIOPENTAL;

EID: 0030876095     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(97)90147-8     Document Type: Article

References (15)

1. Piatt JH, Schiff SJ. High dose barbiturate therapy in neurosurgery and intensive care. Neurosurgery 1984; 15:427-44.
2. Stanski DR, Mihm FG, Rosenthal MH, Kalman SM. Pharmacokinetics of high dose thiopental used in cerebral resuscitation. Anesthesiology 1980;53:169-71.
3. Turcant A, Delhumeau A, Premel-Cabic A, Granry JC, Cottineau C, Six P, et al. Thiopental pharmacokinetics under conditions of long term infusion. Anesthesiology 1985;63:50-4.
4. Russo H, Brès J, Duboin MP, Roquefeuil B. Pharmacokinetics of thiopental after single and multiple intravenous doses in critical care patients. Eur J Clin Pharmacol 1995;49:127-37.
5. Christensen JH, Andreasen F. Individual variation in response to thiopental. Acta Anaesthesiol Scand 1978;22:303-13.
6. Toner W, Howard PJ, Mc Gowan WAW, Dundee JW. Another look at acute tolerance to thiopentone. Br J Anaesth 1980;52:1005-8.
7. Tranchand B, Urien S, Ardiet CJ. Population pharmacokinetics of intravenous melphalan: NONMEM and MP2 analysis [abstract 39]. Proceedings of the third meeting of the Population Approach Group in Europe (PAGE), June 9-10, 1995, Frankfort, Germany.
8. Pandele G, Chaux F, Salvadori C, Farinotti M, Duvaldestin P. Thiopental pharmacokinetics in patients with cirrhosis. Anesthesiology 1983;59:123-6.
9. Burch PG, Stanski DR. Decreased protein binding and thiopental kinetics. Clin Pharmacol Ther 1982;32: 212-7.
10. Christensen JH, Andreasen F, Jansen JA. Pharmacokinetics and pharmacodynamics of thiopentone: a comparison between young and elderly patients. Anaesthesia 1982;37:398-404.
11. Jung D, Mayersohn M, Perrier D, Calkins J, Saunders R. Thiopental disposition in lean and obese patients undergoing surgery. Anesthesiology 1982; 56:269-74.
12. Crankshaw DP, Edwards NE, Blackman GL, Boyd MD, Chan HNJ, Morgan DJ. Evaluation of infusion regimens for thiopentone as a primary anesthetic agent. Eur J Clin Pharmacol 1985;28:543-52.
13. Stanski DR, Maitre PO. Population pharmacokinetics and pharmacodynamics of thiopental: the effect of age revisited. Anesthesiology 1990;72:412-22.
14. Christensen JH, Andreasen F, Jansen JA. Influence of age and sex on the pharmacokinetics of thiopentone. Br J Anaesth 1981;53:1189-95.
15. Christensen JH, Andreasen F, Jansen JA. Pharmacokinetics and pharmacodynamics of thiopental in patients undergoing renal transplantation. Acta Anaesthesiol Scand 1983;27:513-8.